JAMA Ophthalmology

Scope & Guideline

Catalyzing Change in the Field of Ophthalmology

Introduction

Delve into the academic richness of JAMA Ophthalmology with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN2168-6165
PublisherAMER MEDICAL ASSOC
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 2013 to 2024
AbbreviationJAMA OPHTHALMOL / JAMA Ophthalmol.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885

Aims and Scopes

JAMA Ophthalmology focuses on advancing the field of ophthalmology through high-quality research and clinical studies. The journal's aims and scopes encompass a wide range of topics related to eye health and diseases, with an emphasis on evidence-based practices and innovative methodologies.
  1. Research on Eye Diseases and Disorders:
    The journal publishes studies on various ocular conditions, including glaucoma, diabetic retinopathy, age-related macular degeneration, and inherited retinal diseases, focusing on their pathophysiology, diagnosis, and treatment.
  2. Clinical Trials and Therapeutic Interventions:
    JAMA Ophthalmology features randomized clinical trials assessing the efficacy and safety of new therapies, surgical techniques, and interventions in managing ocular diseases.
  3. Public Health and Epidemiology:
    The journal addresses the impact of social determinants on eye health, exploring disparities in access to care, prevalence of eye diseases, and public health initiatives aimed at improving ocular health.
  4. Innovations in Ophthalmic Technology:
    Research on advancements in imaging technologies, artificial intelligence applications, and telemedicine in ophthalmology is a significant focus, highlighting their role in enhancing diagnosis and treatment.
  5. Genetic and Molecular Studies:
    Studies investigating genetic factors related to eye diseases, including genetic mutations and biomarkers, are central to the journal's scope, contributing to personalized medicine in ophthalmology.
  6. Patient-Centered Research:
    Research emphasizing the experiences and perspectives of patients, including quality of life assessments and the psychosocial impact of ocular diseases, is an important component of the journal's aims.
JAMA Ophthalmology is at the forefront of several emerging trends that reflect the evolving landscape of ophthalmic research. This section identifies key themes that have gained momentum in recent publications.
  1. Artificial Intelligence and Machine Learning:
    The integration of AI and machine learning in diagnosing and managing ocular diseases is a rapidly growing focus, with numerous studies exploring its application in retinal imaging and predictive analytics.
  2. Telemedicine and Remote Care:
    The COVID-19 pandemic has accelerated the adoption of telemedicine in ophthalmology, leading to an increase in research on remote monitoring, virtual consultations, and their effectiveness.
  3. Health Equity and Social Determinants of Health:
    There is a growing emphasis on understanding and addressing disparities in eye care access and outcomes, with studies focusing on the influence of socioeconomic and demographic factors.
  4. Gene Therapy and Genetic Research:
    Emerging research on gene therapy for inherited retinal diseases and the role of genetic testing in personalized treatment plans is gaining traction, reflecting advancements in molecular medicine.
  5. Patient-Centered Outcomes and Quality of Life:
    Research that emphasizes the importance of patient-reported outcomes, satisfaction, and quality of life in managing ocular diseases is becoming increasingly prevalent.

Declining or Waning

While JAMA Ophthalmology continues to thrive in various research areas, some themes have seen a decline in prominence over recent years. This section highlights those themes that are gradually receiving less attention in the journal's publications.
  1. Traditional Surgical Techniques:
    There has been a noticeable decrease in the publication of studies focusing on conventional surgical methods as more emphasis is placed on minimally invasive techniques and technological advancements.
  2. General Ophthalmology Topics:
    Research covering broad or general topics in ophthalmology is waning, with more specialized and targeted studies gaining traction, reflecting a shift towards precision medicine.
  3. Pharmacological Interventions without Novelty:
    Papers discussing established pharmacological treatments without new insights or comparative studies are less frequently accepted, indicating a preference for novel therapeutic approaches.
  4. Non-Evidence-Based Practices:
    The journal appears to be moving away from studies that do not employ rigorous evidence-based methodologies, favoring those that provide stronger scientific validation.

Similar Journals

Saudi Journal of Ophthalmology

Empowering Practitioners: Elevating Standards in Ophthalmology
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 1319-4534Frequency: 4 issues/year

Saudi Journal of Ophthalmology, published by Wolters Kluwer Medknow Publications, stands as a crucial platform for the dissemination of innovative research and clinical practices in the field of ophthalmology. Since its inception in 2009, this journal has effectively contributed to the growing body of knowledge with a focus on addressing the diverse visual health challenges faced globally. With an ISSN of 1319-4534 and a E-ISSN of 2542-6680, the journal is indexed in Scopus, where it ranks in the Q3 category of ophthalmology, reflecting its commitment to quality research despite the competitive landscape. Situated in India, it provides a unique regional perspective while facilitating global discourse among researchers, practitioners, and students in ophthalmological sciences. Although it currently does not operate as an open-access journal, the Saudi Journal of Ophthalmology is essential for those aiming to expand their understanding of advancements in eye care, making it a valuable resource for professionals dedicated to enhancing patient outcomes through informed research and clinical practice.

OPHTHALMOLOGICA

Where Vision Meets Innovation and Insight
Publisher: KARGERISSN: 0030-3755Frequency: 6 issues/year

OPHTHALMOLOGICA is a prestigious journal published by KARGER, dedicated to the dynamic field of ophthalmology and its interdisciplinary connections with medicine and sensory systems. With a rich history spanning over a century since its inception in 1899, this journal is esteemed for its high-quality research and impactful contributions, maintaining an impressive Q1 quartile ranking in both ophthalmology and miscellaneous medicine as of 2023, alongside a notable Q2 status in sensory systems. The journal's influence is reinforced by its Scopus rankings, where it ranks 26th out of 137 in ophthalmology, showcasing a strong percentile position of 81. Based in Basel, Switzerland, OPHTHALMOLOGICA serves as an essential platform for researchers, professionals, and students, providing essential insights, reviews, and studies that push the boundaries of knowledge in the vision sciences. Although it does not currently offer open access, its contributions are critical for those pursuing advancements in ocular health and related disciplines.

CURRENT OPINION IN OPHTHALMOLOGY

Navigating the Complexities of Vision Care.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1040-8738Frequency: 6 issues/year

CURRENT OPINION IN OPHTHALMOLOGY is a premier academic journal published by Lippincott Williams & Wilkins, focusing on the dynamic and evolving field of ophthalmology. With an impressive impact factor and a prestigious Q1 ranking in both Medicine (miscellaneous) and Ophthalmology for 2023, this journal is recognized for its authoritative reviews and critical summaries of contemporary research. Since its inception in 1990, the journal has served as an essential resource for ophthalmology professionals, providing insights into the latest advances in clinical practices, emerging technologies, and cutting-edge research. Although not open access, it is highly regarded for its rigorous peer-review process, ensuring the publication of high-quality, relevant findings. Researchers, clinicians, and students alike will find invaluable perspectives in its pages as they navigate the complexities of eye health and patient care.

Ophthalmologie

Elevating Ophthalmic Research and Practice
Publisher: SPRINGER HEIDELBERGISSN: 2731-720XFrequency: 12 issues/year

Ophthalmologie is a distinguished journal published by Springer Heidelberg, specializing in the broad and evolving field of ophthalmology. With an ISSN of 2731-720X and an E-ISSN of 2731-7218, the journal serves as a pivotal platform for disseminating cutting-edge research and clinical advancements in the realm of eye health. As of 2023, it ranks in the third quartile (Q3) within both the general medicine and ophthalmology categories, reflecting its substantial contribution to the academic community and the field's knowledge base. The journal aims to foster collaboration among researchers, medical professionals, and students by offering innovative findings that enhance understanding and treatment of ocular diseases. By nurturing high-quality scholarly discussions, Ophthalmologie plays an essential role in the ongoing development of therapeutic strategies and ophthalmic techniques that ultimately benefit patient care globally. This commitment to excellence is evident as it continues to evolve through its convergence from 1992 to 2023, staying relevant in an ever-changing scientific environment.

SURVEY OF OPHTHALMOLOGY

Pioneering Discoveries in Vision Science
Publisher: ELSEVIER SCIENCE INCISSN: 0039-6257Frequency: 6 issues/year

SURVEY OF OPHTHALMOLOGY is a premier journal published by Elsevier Science Inc, dedicated to advancing knowledge in the field of ophthalmology. With an impact factor reflective of its high-quality research—ranking 7th out of 137 in the Scopus category for medicine and ophthalmology, this journal maintains a prestigious Q1 categorization in its field for 2023. Since its inception in 1956, the journal has provided comprehensive reviews and original articles covering various aspects of ophthalmic research and clinical practice, supporting the ongoing education of researchers, professionals, and students alike. While open access options are not available, the journal remains an essential resource for the latest developments, discoveries, and expert insights that shape the future of eye health. Based in the United States, at STE 800, 230 Park Ave, New York, NY 10169, the journal continues a legacy of excellence in ophthalmology until 2024 and beyond, making it a pivotal element of scholarly discourse in this vital medical discipline.

Seminars in Ophthalmology

Pioneering Research for a Brighter Vision
Publisher: TAYLOR & FRANCIS INCISSN: 0882-0538Frequency: 6 issues/year

Seminars in Ophthalmology is a prestigious journal published by Taylor & Francis Inc, dedicated to advancing knowledge in the field of ophthalmology and related medical areas. Established in 1986, this journal has consistently provided a platform for high-quality research and insights, supporting the community with its impactful publications. With an impressive ranking of #55 out of 137 in the Ophthalmology category, the journal currently holds a Q2 quartile in both ophthalmology and miscellaneous medicine as of 2023, reflecting its significant contribution to the discipline. Researchers and practitioners can access a wealth of information covering a comprehensive range of topics, bolstering both clinical practice and academic inquiry. While not an open-access publication, Seminars in Ophthalmology remains a crucial resource for advancing ophthalmic research, fostering collaboration, and disseminating valuable findings in a rapidly evolving specialty.

BMC Ophthalmology

Innovating Ophthalmology Through Open Access Research
Publisher: BMCISSN: Frequency: 1 issue/year

BMC Ophthalmology is a premier open access journal dedicated to advancing the field of ophthalmology through the publication of high-quality, peer-reviewed research. Published by BMC in the United Kingdom, this journal has been a vital resource since its inception in 2001 and continuously contributes to the global dialogue in vision science. With an impact factor reflecting its growing influence, BMC Ophthalmology is ranked among the top quartiles (Q2) in both general medicine and ophthalmology, emphasizing its significance in medical research. The journal encourages submissions that explore innovative diagnostics, treatment approaches, and understandings of various ocular diseases, thereby appealing to researchers, clinicians, and students alike. As an open access platform, it ensures that cutting-edge research is not only published but also readily accessible to a worldwide audience, promoting further study and collaboration in this essential area of medicine.

INDIAN JOURNAL OF OPHTHALMOLOGY

Advancing Vision: Your Gateway to Ophthalmology Insights
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 0301-4738Frequency: 12 issues/year

The Indian Journal of Ophthalmology is a prestigious, peer-reviewed publication dedicated to advancing the field of ophthalmology. Published by Wolters Kluwer Medknow Publications, this journal plays a vital role in disseminating high-quality research and clinical insights since its inception in 1946. With an impact factor placing it in the Q2 category in Ophthalmology for 2023, it ranks #42 out of 137 in Scopus, reflecting its influence and reliability in the medical community. As an Open Access journal since 2005, it ensures that impactful research is accessible to a global audience, fostering innovation and knowledge sharing among researchers, healthcare professionals, and students alike. The journal's commitment to publishing cutting-edge studies, comprehensive reviews, and clinical guidelines makes it an essential resource for those navigating the rapidly evolving landscape of eye care and ophthalmology.

Journal of the Korean Ophthalmological Society

Cultivating Knowledge for Tomorrow's Eye Care
Publisher: KOREAN OPHTHALMOLOGICAL SOCISSN: 0378-6471Frequency: 12 issues/year

The Journal of the Korean Ophthalmological Society, with ISSN 0378-6471 and E-ISSN 2092-9374, is a pivotal resource in the field of ophthalmology, published by the esteemed Korean Ophthalmological Society. Based in South Korea, this journal is committed to advancing knowledge in ophthalmology through the dissemination of research that spans both clinical and experimental studies. Despite its current Q4 ranking in the 2023 Ophthalmology category, it serves as a crucial platform for emerging scholars, practitioners, and students seeking to contribute to and learn from the latest developments in eye care. While the journal does not currently offer open access, it is dedicated to fostering scientific dialogue and innovation within the community. With convergence years from 2018 to 2024, the journal's focus on contemporary issues in ophthalmology positions it as a relevant and timely source of information, critical for those engaged in this dynamic field. For further inquiries, the journal can be contacted at their address in Seoul, South Korea: SKY 1004 BLDG 701, 50-1 Jungnim-ro, Jung-gu, 04508.

Translational Vision Science & Technology

Advancing the Frontiers of Vision Science and Technology
Publisher: ASSOC RESEARCH VISION OPHTHALMOLOGY INCISSN: 2164-2591Frequency: 6 issues/year

Translational Vision Science & Technology is a premier open access journal dedicated to the advancement of the field of ophthalmology and biomedical engineering. Published by the Association for Research in Vision and Ophthalmology, Inc., this journal has established itself as a leading source of high-quality research since its inception in 2013, achieving a remarkable impact factor reflective of its influential contribution to the field. With an impressive ranking of #21 in Ophthalmology and #120 in Biomedical Engineering within the Scopus database, it sits within the prestigious Q1 quartile for both categories as of 2023, further validating its significance. The journal's scope encompasses a wide variety of topics focused on the intersection of ophthalmological science and technological innovation, welcoming contributions that promote the understanding and treatment of visual disorders. Available as an Open Access publication since 2016, it ensures that cutting-edge research is freely accessible to researchers, practitioners, and students worldwide, facilitating the rapid dissemination of knowledge essential for the advancement of vision science.